Diagnostic accuracy of an "amended" insulin-glucose ratio for the biochemical diagnosis of insulinomas

Annals of Internal Medicine

Volumn 157, Issue 11, 2012, Pages 767-777

  Nauck, Michael A ^a   Meier, Juris J ^b  

^a Diabeteszentrum Bad Lauter berg   (Germany)

^b ST JOSEF HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN;

ADULT; AGED; AMENDED INSULIN GLUCOSE RATIO; ARTICLE; BIOCHEMISTRY; CANCER SURGERY; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DIET RESTRICTION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; GERMANY; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOGLYCEMIA; IMMUNOASSAY; INSULIN BLOOD LEVEL; INSULINOMA; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD;

EID: 84870532000     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-157-11-201212040-00004     Document Type: Article

References (30)

1. Creutzfeldt W, Arnold R, Creutzfeldt C, Deuticke U, Frerichs H, Track NS. Biochemical and morphological investigations of 30 human insulinomas. Correlation between the tumour content of insulin and proinsulin-like components and the histological and ultrastructural appearance. Diabetologia. 1973;9:217-231. [PMID: 4351967]
2. Service FJ, Dale AJ, Elveback LR, Jiang NS. Insulinoma: clinical and diagnostic features of 60 consecutive cases. Mayo Clin Proc. 1976;51:417-429. [PMID: 180358]
3. Nauck MA, Creutzfeldt W. Insulin-producing tumors and the insulinoma syndrome. In: Dayal Y, ed. Endocrine Pathology of the Gut and Pancreas. Boca Raton, FL: CRC Pr; 1991:195-225.
4. Service FJ. Hypoglycemic disorders. N Engl J Med. 1995;332:1144-1152. [PMID: 7700289]
5. Rizza RA, Haymond MW, Verdonk CA, Mandarino LJ, Miles JM, Service FJ, et al. Pathogenesis of hypoglycemia in insulinoma patients: suppression of hepatic glucose production by insulin. Diabetes. 1981;30:377-381. [PMID: 6262168]
6. Mitrakou A, Fanelli C, Veneman T, Perriello G, Calderone S, Platanisiotis D, et al. Reversibility of unawareness of hypoglycemia in patients with insulino-mas. N Engl J Med. 1993;329:834-839. [PMID: 8355741]
7. Marks V, Samols E. Insulinoma: natural history and diagnosis. Clin Gastro-enterol. 1974;3:559-573.
8. Elahi D, Nagulesparan M, Hershcopf RJ, Muller DC, Tobin JD, Blix PM, et al. Feedback inhibition of insulin secretion by insulin: relation to the hyper-insulinemia of obesity. N Engl J Med. 1982;306:1196-1202. [PMID: 7040963]
9. Merimee TJ, Tyson JE. Hypoglycemia in man pathologic and physiologic variants. Diabetes. 1977;26:161-165. [PMID: 190073]
10. Merimee TJ, Tyson JE. Stabilization of plasma glucose during fasting; Normal variations in two separate studies. N Engl J Med. 1974;291:1275-1278. [PMID: 4431434]
11. Cryer PE, Axelrod L, Grossman AB, Heller SR, Montori VM, Seaquist ER, et al; Endocrine Society. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2009;94:709-728. [PMID: 19088155]
12. Turner RC, Oakley NW, Nabarro JD. Control of basal insulin secretion, with special reference to the diagnosis of insulinomas. Br Med J. 1971;2:132-135. [PMID: 4325738]
13. Service FJ, O'Brien PC, Kao PC, Young WF Jr. C-peptide suppression test: effects of gender, age, and body mass index; implications for the diagnosis of insulinoma. J Clin Endocrinol Metab. 1992;74:204-210. [PMID: 1727822]
14. Kimura W, Kuroda A, Morioka Y. Clinical pathology of endocrine tumors of the pancreas. Analysis of autopsy cases. Dig Dis Sci. 1991;36:933-942. [PMID: 2070707]
15. Polonsky KS, Licinio-Paixao J, Given BD, Pugh W, Rue P, Galloway J, et al. Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients. J Clin Invest. 1986; 77:98-105. [PMID: 3511094]
16. Service FJ, O'Brien PC, McMahon MM, Kao PC. C-peptide during the prolonged fast in insulinoma. J Clin Endocrinol Metab. 1993;76:655-659. [PMID: 8445021]
17. Chammas NK, Teale JD, Quin JD. Insulinoma: how reliable is the biochemical evidence? Ann Clin Biochem. 2003;40:689-693. [PMID: 14629810]
18. Vezzosi D, Bennet A, Fauvel J, Caron P. Insulin, C-peptide and proinsulin for the biochemical diagnosis of hypoglycaemia related to endogenous hyper-insulinism. Eur J Endocrinol. 2007;157:75-83. [PMID: 17609405]
19. Melani F, Ryan WG, Rubenstein AH, Steiner DF. Proinsulin secretion by a pancreatic beta-cell adenoma. Proinsulin and C-peptide secretion. N Engl J Med. 1970;283:713-719. [PMID: 4318337]
20. Given BD, Cohen RM, Shoelson SE, Frank BH, Rubenstein AH, Tager HS. Biochemical and clinical implications of proinsulin conversion intermediates. J Clin Invest. 1985;76:1398-1405. [PMID: 3902891]
21. Mohamed-Ali V, Thornton J, Sawicki PT, Yudkin JS. Levels of des64,65 proinsulin in subjects with histologically proven insulinomas (abstract). Diabeto-logia. 1997;40 (Suppl. 1):A96.
22. Kao PC, Taylor RL, Service FJ. Proinsulin by immunochemiluminometric assay for the diagnosis of insulinoma. J Clin Endocrinol Metab. 1994;78:1048-1051. [PMID: 8175958]
23. Gorden P, Skarulis MC, Roach P, Comi RJ, Fraker DL, Norton JA, et al. Plasma proinsulin-like component in insulinoma: a 25-year experience. J Clin Endocrinol Metab. 1995;80:2884-2887. [PMID: 7559869]
24. Heise T, Nosek L, Rønn BB, Endahl L, Heinemann L, Kapitza C, et al. Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes. Diabetes. 2004;53:1614-1620. [PMID: 15161770]
25. Nauck MA, Baum F, Seidensticker F, Røder M, Dinesen B, Creutzfeldt W. A hyperinsulinaemic, sequentially eu- and hypoglycaemic clamp test to characterize autonomous insulin secretion in patients with insulinoma. Eur J Clin Invest. 1997;27:109-115. [PMID: 9061303]
26. Hütter R, Irsigler K, Vesely M, Ogris E. [Hypoglycemic and hyper-insulinemic clamp technic to determine the secretory behavior of insuli-noma]. Dtsch Med Wochenschr. 1988;113:1146-1148. [PMID: 2839328]
27. Rösch T, Lightdale CJ, Botet JF, Boyce GA, Sivak MV jr, Yasuda K, et al. Localization of pancreatic endocrine tumors by endoscopic ultrasonography. N Engl J Med. 1992;326:1721-1726. [PMID: 1317506]
28. Zimmer T, Stölzel U, Bäder M, Koppenhagen K, Hamm B, Buhr H, et al. Endoscopic ultrasonography and somatostatin receptor scintigraphy in the pre-operative localisation of insulinomas and gastrinomas. Gut. 1996;39:562-568. [PMID: 8944566]
29. Wild D, Mäcke H, Christ E, Gloor B, Reubi JC. Glucagon-like peptide 1-receptor scans to localize occult insulinomas [Letter]. N Engl J Med. 2008;359: 766-768. [PMID: 18703486]
30. Christ E, Wild D, Forrer F, Brändle M, Sahli R, Clerici T, et al. Glucagon-like peptide-1 receptor imaging for localization of insulinomas. J Clin Endocrinol Metab. 2009;94:4398-4405. [PMID: 19820010]